Imalogix released the latest version of its diagnostic imaging, interventional radiology, cardiology and surgery platform that supports all radiation and fluoroscopy standards set by The Leapfrog Group and The Joint Commission.
Here are three notes about the new platform:
1. The Imalogix platform enables imaging departments to manage and enhance the safety and quality of exams through a comprehensive view of peak skin dose across their entire patient population.
2. Through calculating PSD, organizations can determine realistic radiation dose estimates for different procedures to better protect patients and physicians.
3. "Without a process to automate the calculations required for interventional procedures, it would be virtually impossible to meet the upcoming requirements from The Joint Commission," said John Heil, co-founder and CEO of Imalogix. "Our platform makes this process simple, while providing insights to departments to understand how procedures are being delivered to enhance patient safety."